CN Patent

CN101014608A — 抑制基因表达的方法和组合物

Assigned to Sierra Oncology Inc · Expires 2007-08-08 · 19y expired

What this patent protects

本发明涉及用于抑制基因表达的方法和组合物。具体的说，本发明提供基于寡核苷酸的治疗药物，以抑制与癌症相关的癌基因。

USPTO Abstract

本发明涉及用于抑制基因表达的方法和组合物。具体的说，本发明提供基于寡核苷酸的治疗药物，以抑制与癌症相关的癌基因。

Drugs covered by this patent

resmetirom (RESMETIROM)

Patent Metadata

Patent number: CN101014608A
Jurisdiction: CN
Classification: —
Expires: 2007-08-08
Drug substance claim: No
Drug product claim: No
Assignee: Sierra Oncology Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.